Skip to main content
. 2011 Sep 20;2011:803948. doi: 10.5402/2011/803948

Figure 2.

Figure 2

Patients' assessment of treatment with NordiFlex with NordiFlex PenMate at the end of the observation period (mean 17 ± 7 weeks) (n = 79).